Biotech News Brief

Biotech news for Sunday, June 14, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.

Jun 11, 8:21 AM EDT

Summit Therapeutics withdraws proposed securities offering citing market conditions

SMMT

Summit Therapeutics ( SMMT ) announced that effective June 10, 2026, it has withdrawn its previously announced proposed underwritten public offering of securities due to market conditions. Earlier this week, the firm had proposed a public offering of $500M of…

Jun 11, 8:19 AM EDT

Atossa Therapeutics prices up to $16.5M direct offering

ATOS

Atossa Therapeutics ( ATOS ) said on Thursday it entered into a registered direct offering with institutional investors for 1.36M shares, or common stock equivalents, along with warrants to purchase up to 2.73M shares, with potential gross proceeds of up to $1…

← Back to the latest News Brief